Literature DB >> 22753939

Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli.

Madeleine E Gentle1, Anna Rose, Laurence Bugeon, Margaret J Dallman.   

Abstract

Dendritic cell (DC)-derived cytokines play a key role in specifying adaptive immune responses tailored to the type of pathogen encountered and the local tissue environment. However, little is known about how DCs perceive the local environment. We investigated whether endogenous Notch signaling could affect DC responses to pathogenic stimuli. We demonstrate that concurrent Notch and TLR stimulation results in a unique cytokine profile in mouse bone-marrow derived DCs characterized by enhanced IL-10 and IL-2, and reduced IL-12 expression compared with TLR ligation alone. Unexpectedly, modulation of cytokine production occurred through a noncanonical Notch signaling pathway, independent of γ-secretase activity. Modulation required de novo protein synthesis, and PI3K, JNK, and ERK activity were necessary for enhanced IL-2 expression, whereas modulation of IL-10 required only PI3K activity. Further, we show that this γ-secretase-independent Notch pathway can induce PI3K activity. In contrast, expression of the canonical Notch target gene Hes1 was suppressed in DCs stimulated with Notch and TLR ligands simultaneously. Thus, our data suggest that Notch acts as an endogenous signal that modulates cytokine expression of DCs through a noncanonical pathway and therefore has the potential to tailor the subsequent adaptive immune response in a tissue- and/or stage-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753939      PMCID: PMC3442230          DOI: 10.4049/jimmunol.1103102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis.

Authors:  K Kuroda; S Tani; K Tamura; S Minoguchi; H Kurooka; T Honjo
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

3.  Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Immunol       Date:  2005-07-31       Impact factor: 25.606

4.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

5.  Notch-1 up-regulation and signaling following macrophage activation modulates gene expression patterns known to affect antigen-presenting capacity and cytotoxic activity.

Authors:  Eva Monsalve; Miguel A Pérez; Antonio Rubio; María José Ruiz-Hidalgo; Victoriano Baladrón; José J García-Ramírez; Juan C Gómez; Jorge Laborda; María José M Díaz-Guerra
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

6.  Notch signalling regulates stem cell numbers in vitro and in vivo.

Authors:  Andreas Androutsellis-Theotokis; Ronen R Leker; Frank Soldner; Daniel J Hoeppner; Rea Ravin; Steve W Poser; Maria A Rueger; Soo-Kyung Bae; Raja Kittappa; Ronald D G McKay
Journal:  Nature       Date:  2006-06-25       Impact factor: 49.962

7.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.

Authors:  Michael Reedijk; Silvia Odorcic; Lynn Chang; Hui Zhang; Naomi Miller; David R McCready; Gina Lockwood; Sean E Egan
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

8.  Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.

Authors:  Ezra Aksoy; Wim Vanden Berghe; Sophie Detienne; Zoulikha Amraoui; Kathrine A Fitzgerald; Guy Haegeman; Michel Goldman; Fabienne Willems
Journal:  Eur J Immunol       Date:  2005-07       Impact factor: 5.532

9.  Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.

Authors:  Sathish Kumar Mungamuri; Xiaohe Yang; Ann D Thor; Kumaravel Somasundaram
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 10.  Presenilin diversifies its portfolio.

Authors:  Annette L Parks; Daniel Curtis
Journal:  Trends Genet       Date:  2007-02-05       Impact factor: 11.639

View more
  17 in total

1.  Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.

Authors:  Karina Kristoffersen; Mette Kjølhede Nedergaard; Mette Villingshøj; Rehannah Borup; Helle Broholm; Andreas Kjær; Hans Skovgaard Poulsen; Marie-Thérése Stockhausen
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 2.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

3.  TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.

Authors:  Matthias Vanderkerken; Bastiaan Maes; Lana Vandersarren; Wendy Toussaint; Kim Deswarte; Manon Vanheerswynghels; Philippe Pouliot; Liesbet Martens; Sofie Van Gassen; Connie M Arthur; Margaret E Kirkling; Boris Reizis; Daniel Conrad; Sean Stowell; Hamida Hammad; Bart N Lambrecht
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-19       Impact factor: 11.205

Review 4.  Impact of notch signaling on inflammatory responses in cardiovascular disorders.

Authors:  Thibaut Quillard; Beatrice Charreau
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

Review 5.  Targeting the Notch signaling pathway in cancer therapeutics.

Authors:  Huajiao Guo; Yi Lu; Jianhua Wang; Xia Liu; Evan T Keller; Qian Liu; Qinghua Zhou; Jian Zhang
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

6.  Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis.

Authors:  Lei Wang; Shuiliang Yu; Ernest R Chan; Kai-Yuan Chen; Cui Liu; Danian Che; Amad Awadallah; Jay Myers; David Askew; Alex Y Huang; Ivan Maillard; Dan Huang; Wei Xin; Lan Zhou
Journal:  Cancer Immunol Res       Date:  2021-01-13       Impact factor: 12.020

Review 7.  Non-canonical notch signaling in cancer and immunity.

Authors:  Furkan Ayaz; Barbara A Osborne
Journal:  Front Oncol       Date:  2014-12-04       Impact factor: 6.244

Review 8.  The immunological synapse: the gateway to the HIV reservoir.

Authors:  Deanna A Kulpa; Jessica H Brehm; Rémi Fromentin; Anthony Cooper; Colleen Cooper; Jeffrey Ahlers; Nicolas Chomont; Rafick-Pierre Sékaly
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  A novel non-canonical Notch signaling regulates expression of synaptic vesicle proteins in excitatory neurons.

Authors:  Yukari Hayashi; Hiroshi Nishimune; Katsuto Hozumi; Yumiko Saga; Akihiro Harada; Michisuke Yuzaki; Takeshi Iwatsubo; Raphael Kopan; Taisuke Tomita
Journal:  Sci Rep       Date:  2016-04-04       Impact factor: 4.379

10.  Interleukin-6 (IL-6) Activates the NOTCH1 Signaling Pathway Through E-Proteins in Endometriotic Lesions.

Authors:  Yong Song; Ren-Wei Su; Niraj R Joshi; Tae Hoon Kim; Bruce A Lessey; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.